Clinical evaluation of Luhong compound in improving myocardial fibrosis in patients with chronic heart failure
Phase 1
- Conditions
- Myocardial fibrosis in patients with chronic heart failure
- Registration Number
- ITMCTR2000003797
- Lead Sponsor
- Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) According to the diagnostic criteria of stage C of heart failure;
(2) The age ranged from 18 to 80 years old;
(3) The clinical observation data were collected completely;
(4) The subjects agreed to test the relevant clinical indicators.
Exclusion Criteria
(1) Patients with definite multi system infection, tumor, connective tissue disease, autoimmune disease, recent operation or trauma;
(2) Moderate to severe dementia or mental illness can not cooperate with follow-up investigation;
(3) Pregnant and lactating women;
(4) The patients died in the acute phase.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method P III NP, PICP, Serum levels of type I and type III collagen;
- Secondary Outcome Measures
Name Time Method